{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:49:14Z","timestamp":1757616554407,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2007,5,4]]},"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background and methodology<\/jats:title>\n                  <jats:p>This observational study aimed to establish prevalence of high-risk human papillomaviruses (hrHPV) in women attending three inner London community clinics for routine screening and to pilot hrHPV testing in the triage of either borderline or negative cytology after previous abnormalities. Hybrid Capture\u00ae 2 was carried out on brush samples taken alongside conventional smears from 1434 women aged 20\u201349 years. hrHPV positivity prompted earlier referral of women with previous abnormalities and either low-grade or negative cytology. Outcome at colposcopy was compared with the records of 1871 women aged 20\u201349 years attending colposcopy during the same period of time (routine colposcopies).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>hrHPV was detected in 111\/161 (68.9%) women with abnormal cytology, 76\/460 (16.5%) with negative cytology after previous abnormalities and 105\/813 (12.9%) with negative cytology and no previous abnormalities. Overall, hrHPV was detected in 292\/1434 (20.4%) women in the study (95% CI 18.3\u201322.5). hrHPV prevalence increased with severity of cytological abnormality (<jats:italic>p<\/jats:italic>&lt;0.001) and decreased with age both with negative and low-grade cytology (p&lt;0.001). High-grade cervical intraepithelial neoplasia (CIN) biopsies were found more frequently in women in the study groups with low-grade (<jats:italic>p<\/jats:italic>&lt;0.001) or negative cytology than in routine colposcopies, but more women in the study groups attended colposcopy (8.2% compared with 4.1% routine colposcopies, <jats:italic>p<\/jats:italic>&lt;0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>hrHPV positivity increased detection of high-grade CIN in the study groups at the expense of more colposcopies. hrHPV negativity could reduce the need for investigation of low-grade cytology in women aged over 35 years and for surveillance after previous abnormalities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1783\/147118907781005074","type":"journal-article","created":{"date-parts":[[2007,6,24]],"date-time":"2007-06-24T19:01:55Z","timestamp":1182711715000},"page":"171-176","source":"Crossref","is-referenced-by-count":1,"title":["Human papillomavirus testing with conventional Pap smear screening in three inner London community clinics"],"prefix":"10.1136","volume":"33","author":[{"given":"Amanda","family":"Herbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmjit","family":"Chana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Culora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ktori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A","family":"Kubba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"Dunsmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2007,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers, J.M.; Jacobs, M.V.; Manos, M.M.; Bosch, F.X.; Kummer, J.A.; Shah, K.V.","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12\u201319.","journal-title":"J Pathol"},{"key":"ref_2","first-page":"59","article-title":"International Agency for Research on Cancer (IARC). Cervix Cancer Screening (IARC Handbook of Cancer","volume":"10","year":"2005","unstructured":"International Agency for Research on Cancer (IARC). Cervix Cancer Screening (IARC Handbook of Cancer Prevention, Vol. 10). Lyon, France: IARC, 2005; 59\u2013115.","journal-title":"Prevention"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.5858\/2003-127-959-HPDTAA","article-title":"Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs","volume":"127","author":"Lorincz, A.T.; Richart, R.M.","year":"2003","unstructured":"Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003; 127: 959\u2013968.","journal-title":"Arch Pathol Lab Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.38701.440961.7C","article-title":"Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study","volume":"332","author":"Moss, S.; Gray, A.; Legood, R.; Vessey, M.; Patnick, J.; Kitchener, H.","year":"2006","unstructured":"Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ 2006; 332: 83\u201385.","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"et al.; ARTISTIC Trial Study Group. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener, H.C.; Almonte, M.; Wheeler, P.; Desai, M.; Gilham, C.; Bailey, A.","year":"2006","unstructured":"Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, et al.; ARTISTIC Trial Study Group. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 2006; 95: 56\u201361.","journal-title":"Br J Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","year":"2003","unstructured":"ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383\u20131392.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","article-title":"ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations","volume":"188","year":"2003","unstructured":"ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188: 1393\u20131400.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virological versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn, M.; Buntinx, F.; Van Ranst, M.; Paraskevaidis, E.; Martin-Hirsch, P.; Dillner, J.","year":"2004","unstructured":"Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virological versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004; 96: 280\u2013293.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"ref_9","first-page":"78","article-title":"Chapter 9: Clinical applications of HPV testing: A summary of metaanalyses","volume":"24","author":"Arbyn, M.; Sasieni, P.; Meijer, C.J.; Koliopoulos, G.; Dillner, J.","year":"2006","unstructured":"Arbyn M, Sasieni P, Meijer CJ, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: A summary of metaanalyses. Vaccine 2006; 24(Suppl. 3): S78\u2013S89.","journal-title":"Vaccine"},{"key":"ref_10","article-title":"Cervical Screening Programme, England: 2002\u201303","author":"Department of Health","year":"2003","unstructured":"Department of Health. Cervical Screening Programme, England: 2002\u201303. London, UK Department of Health, 2003."},{"key":"ref_11","article-title":"Cervical Screening Programme (NHSCSP). Colposcopy and Programme Management: Guidelines for the NHS Cervical Screening Programme (NHSCSP Publication No. 20)","author":"NHS","year":"2004","unstructured":"NHS Cervical Screening Programme (NHSCSP). Colposcopy and Programme Management: Guidelines for the NHS Cervical Screening Programme (NHSCSP Publication No. 20). Sheffield, UK: NHSCSP, April 2004."},{"key":"ref_12","article-title":"Clinical Excellence (NICE). Guidance on the Use of Liquid-based Cytology for Cervical Screening (Technology Appraisal Guidance No","author":"National Institute for","year":"2000","unstructured":"National Institute for Clinical Excellence (NICE). Guidance on the Use of Liquid-based Cytology for Cervical Screening (Technology Appraisal Guidance No. 5). London, UK: NICE, 2000."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1054\/bjoc.2001.1845","article-title":"Human papillomavirus in primary screening for the detection of high-grade cervical lesions: a study of 7932 women","volume":"84","author":"Clavel, C.; Masure, M.; Bory, J.P.; Putand, I.; Mangeonjean, C.; Lorenzato, M.","year":"2001","unstructured":"Clavel C, Masure M, Bory JP, Putand I, Mangeonjean C, Lorenzato M, et al. Human papillomavirus in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001; 84: 1616\u20131623.","journal-title":"Br J Cancer"},{"key":"ref_14","first-page":"193","article-title":"Test for trend across ordered groups revisited","volume":"6","author":"Sasieni, P.; Stepniewska, K.; Altman, D.","year":"1996","unstructured":"Sasieni P, Stepniewska K, Altman D. Test for trend across ordered groups revisited. Stata Technical Bulletin 1996; 6: 193\u2013196.","journal-title":"Stata Technical Bulletin"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick, J.; Szarewski, A.; Cubie, H.; Hulman, G.; Kitchener, H.; Luesley, D.","year":"2003","unstructured":"Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871\u20131876.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/428779","article-title":"A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica","volume":"191","author":"Castle, P.E.; Schiffman, M.; Herrero, R.; Hildesheim, A.; Rodriguez, A.C.; Bratti, M.C.","year":"2005","unstructured":"Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1808\u20131816.","journal-title":"J Infect Dis"},{"key":"ref_17","first-page":"972","article-title":"Optimizing the hybrid capture human papillomavirus test to detect cervical intra-epithelial neoplasia","volume":"100","author":"Howard, M.; Sellors, J.; Kaczorowski, J.","year":"2002","unstructured":"Howard M, Sellors J, Kaczorowski J. Optimizing the hybrid capture human papillomavirus test to detect cervical intra-epithelial neoplasia. Obstet Gynecol 2002; 100: 972\u2013980.","journal-title":"Obstet Gynecol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ejca.2004.01.021","article-title":"Detection of cervical precancer and cancer in a hospital population: benefits of testing for human papillomavirus","volume":"40","author":"Dalstein, V.; Riethmuller, D.; Sauti\u00e8re, J.L.; Pretet, J.L.; Kantelip, B.; Schaal, J.P.","year":"2004","unstructured":"Dalstein V, Riethmuller D, Sauti\u00e8re JL, Pretet JL, Kantelip B, Schaal JP, et al. Detection of cervical precancer and cancer in a hospital population: benefits of testing for human papillomavirus. Eur J Cancer 2004; 40: 1225\u20131232.","journal-title":"Eur J Cancer"},{"author":"[27 April 2007].","key":"ref_19","unstructured":"National Statistics Online. http:\/\/www.statistics.gov.uk\/cci\/nugget.asp?id=915 [Accessed 27 April 2007]."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2303.2004.00193.x","article-title":"BSCC terminology for cervical cytology: two or three tiers? Why not five, seven or fourteen?","volume":"14","author":"Herbert, A.","year":"2004","unstructured":"Herbert A. BSCC terminology for cervical cytology: two or three tiers? Why not five, seven or fourteen? Cytopathology 2004; 14: 245\u2013251.","journal-title":"Cytopathology"},{"key":"ref_21","article-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes","author":"Solomon, D.; Nayar, R.","year":"2004","unstructured":"Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes (2nd edn). New York, NY: Springer Verlag, 2004.","edition":"2nd edn"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/bmj.331.7522.915","article-title":"Cervical cancer, human papillomavirus, and vaccination","volume":"331","author":"Lowndes, C.M.; Gill, O.N.","year":"2005","unstructured":"Lowndes CM, Gill ON. Cervical cancer, human papillomavirus, and vaccination. BMJ 2005; 331: 915\u2013916.","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(86)92942-9","article-title":"Diagnostic vigilance","volume":"I:","author":"Fowkes, F.G.R.","year":"1986","unstructured":"Fowkes FGR. Diagnostic vigilance. Lancet 1986; I: 493\u2013494.","journal-title":"Lancet"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118907781005074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:26:38Z","timestamp":1757100398000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118907781005074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,7,1]]},"published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1783\/147118907781005074"],"URL":"https:\/\/doi.org\/10.1783\/147118907781005074","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}